Pfizer adds to obesity bet with up to $2.1 billion deal to develop Chinese company's pill

Thread starter U.S. News
Start date Dec 9, 2025

U.S. News

Guest

Dec 9, 2025

The deal will help Pfizer beef up and diversify its obesity drug pipeline following its $10 billion acquisition of obesity biotech Metsera last month.

Continue reading...

You must log in or register to reply here.

Facebook X Bluesky LinkedIn Reddit Pinterest Tumblr WhatsApp Email Link

Thread Information

Title: Pfizer adds to obesity bet with up to $2.1 billion deal to develop Chinese company's pill

Prefix: N/A

Forum: USA News

Start date: Dec 9, 2025

Last reply date: Dec 9, 2025

Replies: 0

Thread Tags

Thread statistics

Created: U.S. News, Dec 9, 2025

Replies: 0

Views: 8

About Us

XenTR Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.

It is a long established fact that a reader will be distracted by the readable content of a page when looking at its layout.

Color picker

Search